BioNexus Gene Lab (BGLC) Interest Expenses (2021 - 2026)
BioNexus Gene Lab recorded quarterly Interest Expenses of $3085.0 in Q1 2026, down 5.72% quarter-over-quarter from $3272.0 in Q4 2025, and down 37.16% year-over-year from $4909.0 in Q1 2025.
BioNexus Gene Lab's Interest Expenses history runs 6 years deep, the most recent figure standing at $3085.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 37.16% year-over-year to $3085.0; the TTM figure through Mar 2026 stood at $17718.0 (down 17.18% YoY), while the FY2025 annual figure was $19542.0, down 7.59% from the prior year.
- Interest Expenses came in at $3085.0 for Q1 2026 at BioNexus Gene Lab, down from $3272.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $6482.0 in Q3 2025 to a low of -$4762.0 in Q4 2022.
- A 5-year average of $2678.8 and a median of $4183.0 in 2023 frame the typical range for Interest Expenses.
- On a YoY basis, Interest Expenses climbed as much as 305.55% in 2023 and fell as far as 231.18% in 2023.
- BioNexus Gene Lab's Interest Expenses stood at -$4762.0 in 2022, then surged by 187.84% to $4183.0 in 2023, then soared by 38.94% to $5812.0 in 2024, then tumbled by 43.7% to $3272.0 in 2025, then dropped by 5.72% to $3085.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $3085.0, $3272.0, and $6482.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 62.00 Mn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | -53.70 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 131.60 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | -64.30 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 49.50 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 61.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 138.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | - |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 40.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | 3,085.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,085.00 |
| Mar 31, 2026 | 3,085.00 |
| Dec 31, 2025 | 3,272.00 |
| Dec 31, 2025 | 3,272.00 |
| Sep 30, 2025 | 6,482.00 |
| Sep 30, 2025 | 6,482.00 |
| Jun 30, 2025 | 4,879.00 |
| Jun 30, 2025 | 4,879.00 |
| Mar 31, 2025 | 4,909.00 |
| Mar 31, 2025 | 4,909.00 |
| Dec 31, 2024 | 5,812.00 |
| Dec 31, 2024 | 5,812.00 |
| Sep 30, 2024 | 6,193.00 |
| Sep 30, 2024 | 6,193.00 |
| Jun 30, 2024 | 4,480.00 |
| Jun 30, 2024 | 4,480.00 |
| Mar 31, 2024 | 4,661.00 |
| Mar 31, 2024 | 4,661.00 |
| Dec 31, 2023 | 4,183.00 |
| Dec 31, 2023 | 4,183.00 |
| Sep 30, 2023 | 4,259.00 |
| Sep 30, 2023 | 4,259.00 |
| Jun 30, 2023 | -3,042.00 |
| Jun 30, 2023 | -3,042.00 |
| Mar 31, 2023 | -2,445.00 |
| Mar 31, 2023 | -2,445.00 |
| Dec 31, 2022 | -4,762.00 |
| Dec 31, 2022 | -4,762.00 |
| Sep 30, 2022 | -2,072.00 |
| Sep 30, 2022 | -2,072.00 |
| Jun 30, 2022 | 2,319.00 |
| Jun 30, 2022 | 2,319.00 |
| Mar 31, 2022 | 3,326.00 |
| Mar 31, 2022 | 3,326.00 |
| Dec 31, 2021 | -3,986.00 |
| Dec 31, 2021 | -3,986.00 |
| Sep 30, 2021 | -2,150.00 |
| Sep 30, 2021 | -2,150.00 |
| Jun 30, 2021 | 3,448.00 |
| Jun 30, 2021 | 3,448.00 |